Related Experiment Videos
Neonatal medulloblastoma
T Kayama1, T Yoshimoto, H Shimizu
1Division of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
Journal of Neuro-Oncology
|February 1, 1993
Summary
This case study details a neonatal medulloblastoma treated with surgery, radiation, and chemotherapy. Despite initial improvements, the infant experienced tumor recurrence and spinal cord involvement, highlighting the poor prognosis for neonatal brain tumors.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Neonatal Medicine
Background:
- Neonatal medulloblastoma is a rare and aggressive brain tumor with a historically poor prognosis.
- Early diagnosis and intervention are critical for managing hydrocephalus and large tumor burdens in neonates.
Observation:
- A 9-day-old female presented with symptoms of increased intracranial pressure, including vomiting and head enlargement.
- Imaging revealed a large infra- and supratentorial medulloblastoma with significant hydrocephalus.
- The infant underwent ventriculoperitoneal shunting, tumor resection, whole-brain and tumor-site irradiation, and chemotherapy with ACNU.
Findings:
- Post-treatment, the patient showed initial neurological improvement but later developed spinal cord compression.
- Treatment included radiation to the spinal cord, which led to partial recovery of motor function.
- Despite aggressive multimodal therapy, the patient experienced intracranial tumor recurrence and ultimately succumbed to the disease at 9.3 months of age.
Implications:
- This case contributes to the limited data on neonatal medulloblastoma, suggesting a prolonged survival compared to some previous reports.
- The case underscores the challenges in treating neonatal brain tumors and the need for further research into effective therapeutic strategies.
- Multimodal treatment approaches, including surgery, radiation, and chemotherapy, are discussed in the context of improving outcomes for this rare condition.